nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00843	0.0671	CbGeAlD
Darifenacin—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00833	0.0663	CbGeAlD
Darifenacin—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00811	0.0646	CbGeAlD
Darifenacin—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00758	0.0604	CbGeAlD
Darifenacin—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00704	0.0561	CbGeAlD
Darifenacin—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00678	0.054	CbGeAlD
Darifenacin—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00659	0.0524	CbGeAlD
Darifenacin—CHRM4—brain—attention deficit hyperactivity disorder	0.00644	0.0513	CbGeAlD
Darifenacin—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00641	0.051	CbGeAlD
Darifenacin—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00634	0.0505	CbGeAlD
Darifenacin—CHRM5—brain—attention deficit hyperactivity disorder	0.00503	0.0401	CbGeAlD
Darifenacin—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00452	0.036	CbGeAlD
Darifenacin—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00435	0.0347	CbGeAlD
Darifenacin—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00411	0.0328	CbGeAlD
Darifenacin—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00396	0.0315	CbGeAlD
Darifenacin—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00368	0.0293	CbGeAlD
Darifenacin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00367	0.0292	CbGeAlD
Darifenacin—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00354	0.0282	CbGeAlD
Darifenacin—CHRM2—brain—attention deficit hyperactivity disorder	0.00346	0.0275	CbGeAlD
Darifenacin—CHRM1—brain—attention deficit hyperactivity disorder	0.00314	0.025	CbGeAlD
Darifenacin—CHRM3—brain—attention deficit hyperactivity disorder	0.00281	0.0224	CbGeAlD
Darifenacin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00202	0.0161	CbGeAlD
Darifenacin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00199	0.0159	CbGeAlD
Darifenacin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00195	0.0155	CbGeAlD
Darifenacin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00192	0.0153	CbGeAlD
Darifenacin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00187	0.0149	CbGeAlD
Darifenacin—CYP2D6—brain—attention deficit hyperactivity disorder	0.00152	0.0121	CbGeAlD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000741	0.000848	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000738	0.000844	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000736	0.000841	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000735	0.00084	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000729	0.000834	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000729	0.000833	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000727	0.000831	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000727	0.000831	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000724	0.000828	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00072	0.000823	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000718	0.000821	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000717	0.00082	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000717	0.00082	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000716	0.000819	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000705	0.000807	CbGpPWpGaD
Darifenacin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000691	0.00079	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000687	0.000786	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000679	0.000777	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000677	0.000774	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000676	0.000773	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00067	0.000767	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000642	0.000735	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00064	0.000732	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000635	0.000726	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000633	0.000724	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000627	0.000717	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000609	0.000696	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000605	0.000692	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000603	0.000689	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000597	0.000683	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000592	0.000678	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000591	0.000675	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00059	0.000675	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000589	0.000673	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000585	0.000669	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000583	0.000667	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000583	0.000667	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000572	0.000654	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00057	0.000652	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000565	0.000647	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000565	0.000646	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000562	0.000643	CbGpPWpGaD
Darifenacin—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000561	0.000642	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00056	0.000641	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00056	0.00064	CbGpPWpGaD
Darifenacin—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000558	0.000638	CbGpPWpGaD
Darifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000555	0.000635	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000555	0.000635	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000555	0.000635	CbGpPWpGaD
Darifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000553	0.000633	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000553	0.000633	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000553	0.000632	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000549	0.000628	CbGpPWpGaD
Darifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000548	0.000627	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000548	0.000627	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000547	0.000626	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000542	0.00062	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000538	0.000615	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000537	0.000614	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000536	0.000613	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000536	0.000613	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000532	0.000609	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000531	0.000607	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00053	0.000606	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000517	0.000591	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000516	0.00059	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000514	0.000588	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000511	0.000584	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00051	0.000583	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000495	0.000566	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000484	0.000553	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000483	0.000553	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000482	0.000551	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000481	0.00055	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000479	0.000548	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000477	0.000546	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000476	0.000544	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000474	0.000542	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000474	0.000542	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000471	0.000539	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000471	0.000539	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00047	0.000537	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000465	0.000532	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000463	0.000529	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000462	0.000529	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000461	0.000527	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000459	0.000525	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000451	0.000516	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000451	0.000516	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000449	0.000514	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000446	0.00051	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000443	0.000506	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000435	0.000498	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000434	0.000497	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000433	0.000496	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00043	0.000492	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000428	0.000489	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000423	0.000483	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000417	0.000477	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000415	0.000475	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000411	0.00047	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00041	0.000469	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000409	0.000468	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000405	0.000464	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000405	0.000463	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000394	0.00045	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000387	0.000442	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000378	0.000432	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000377	0.000431	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000376	0.00043	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000373	0.000426	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000373	0.000426	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000372	0.000425	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00037	0.000423	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000368	0.000421	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000367	0.00042	CbGpPWpGaD
Darifenacin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000365	0.000417	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000362	0.000414	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000361	0.000413	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000359	0.000411	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000359	0.00041	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000358	0.000409	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000358	0.000409	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000354	0.000405	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000334	0.000382	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000333	0.00038	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000329	0.000377	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000327	0.000374	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000326	0.000373	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000325	0.000372	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000324	0.000371	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000323	0.00037	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000323	0.00037	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000322	0.000368	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000322	0.000368	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00032	0.000366	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000319	0.000365	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000318	0.000363	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000318	0.000363	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000317	0.000362	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000317	0.000362	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000314	0.000359	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000314	0.000359	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000314	0.000359	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000313	0.000358	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000313	0.000358	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000312	0.000356	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000311	0.000355	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00031	0.000354	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000308	0.000352	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000304	0.000347	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000303	0.000347	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000302	0.000345	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000299	0.000342	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000293	0.000336	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000293	0.000335	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000292	0.000334	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000291	0.000333	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000291	0.000332	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00029	0.000331	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000289	0.00033	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000288	0.00033	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000288	0.000329	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000286	0.000327	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000285	0.000326	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000285	0.000326	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000284	0.000325	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000281	0.000322	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000276	0.000315	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000273	0.000313	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000267	0.000305	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000267	0.000305	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000265	0.000304	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000265	0.000304	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000265	0.000303	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000264	0.000302	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000263	0.0003	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000262	0.0003	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000257	0.000294	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000254	0.000291	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000253	0.000289	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00025	0.000285	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000246	0.000282	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000244	0.000279	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000242	0.000277	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000239	0.000273	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000233	0.000266	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000231	0.000264	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000223	0.000255	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00022	0.000252	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00022	0.000251	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000217	0.000249	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000213	0.000244	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000205	0.000234	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000204	0.000233	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000203	0.000232	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000202	0.000231	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000193	0.00022	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000192	0.00022	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00019	0.000217	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000186	0.000213	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000185	0.000212	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000183	0.00021	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000179	0.000205	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000178	0.000204	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000177	0.000202	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000173	0.000198	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000173	0.000198	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000171	0.000196	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00017	0.000195	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00017	0.000194	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000168	0.000192	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.000192	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000168	0.000192	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000166	0.00019	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000163	0.000186	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000162	0.000185	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000161	0.000184	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00016	0.000183	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00016	0.000183	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000157	0.00018	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000157	0.000179	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000156	0.000179	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000156	0.000178	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000155	0.000177	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000151	0.000173	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000146	0.000167	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000128	0.000146	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000121	0.000139	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00011	0.000126	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000109	0.000125	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000108	0.000124	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000104	0.000119	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000104	0.000119	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000103	0.000117	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	9.67e-05	0.000111	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.6e-05	0.00011	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.54e-05	0.000109	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.63e-05	9.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.34e-05	9.54e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.26e-05	9.45e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.94e-05	9.08e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.94e-05	7.93e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.32e-05	7.23e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.28e-05	7.18e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.82e-05	6.65e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.8e-05	6.63e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.74e-05	6.57e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.15e-05	4.74e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.71e-05	3.1e-05	CbGpPWpGaD
